ARCHIVES

Science Policy: All’s Well In Access to Trials, GAO Study Finds; NIH Disagrees

This article is from The Cancer Letter archive.

Vol. 25 No. 42 | November 5, 1999

Download PDF Visit The Full Archive

Related Articles

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

January 30, 2009

Long-term Hormonal Therapy Adds No Additional Benefits

September 27, 2013

Part One Of A Two-Part Interview With NCI Director Harold Varmus

July 22, 2011

In Brief: Some Cancer Centers Funded At “Recommended” Levels For Fiscal 1981, But There Was A Catch

October 30, 1981

Men Over Age 75 Shouldn’t Be Screened For Prostate Cancer, Task Force Says

August 29, 2008

Clinical Trials Approved By NCI Last Month

March 29, 2002